Alfred Health's Victorian Melanoma Service is currently conducting a trial into the effectiveness of artificial intelligence for assessments of skin cancer, directly comparing AI results with those of doctors.

The study is designed to be able to prove if the MoleMap algorithm can be used as a diagnostic aid in a specialist setting prior to conducting a much larger trial of the intervention in primary care.